During the past decade, Sierra Clinical Research conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 6 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 6 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sierra Clinical Research" #1 sponsor was "Pfizer" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Phathom Pharmaceuticals, Inc." with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "ByHeart" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sierra Clinical Research" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Paidion Research, Inc." with 2 trials as a collaborator, "Inogen Inc." with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sierra Clinical Research" are "Nonalcoholic Steatohepatitis" (3 trials), "Ulcerative Colitis" (3 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Crohn's Disease" (2 trials) and "Nonalcoholic Fatty Liver Disease" (2 trials). Many other conditions were trialed in "Sierra Clinical Research" in a lesser frequency.

Most popular intervention types in "Sierra Clinical Research" are "Drug" (19 trials), "Other" (5 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Etrasimod" (4 trials), "Vonoprazan" (3 trials), "Comparator Formula (CF)" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sierra Clinical Research" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Sierra Clinical Research". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Sierra Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sierra Clinical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".